Search

Search Constraints

You searched for: Author/Creator Isebaert, S.

Search Results

1. EP-1552 Impact of MRI on prostate cancer risk classification: game changer for therapeutic decision making?. (April 2019)

3. OC-0056: FLAME: Influence of dose escalation to 95Gy for prostate cancer on urethra-related toxicity and QOL. (April 2016)

4. OC-0160 When PI-RADS and ISUP meet each other: identification of candidates for pelvic lymph node dissection. (April 2019)

5. OC-0209: 'SBRT and the Boost', a love story: primary endpoint analysis of the phase II hypo-FLAME trial. (November 2020)

6. OC-0259 Focal boosting in prostate cancer: risk modelling for individualized therapy. (May 2022)

7. OC-0282: FLAME randomised trial: 95Gy MRI-boost vs 77Gy prostate radiotherapy: toxicity and quality of life. (April 2016)

8. OC-0315: Quality of life after EBRT with or without focal boost for prostate cancer in the FLAME trial. (November 2020)

9. OC-0511 Urethra and bladder dose-effect relations for genitourinary toxicity after EBRT for prostate cancer. (August 2021)

10. OC-0612: The FLAME trial: benefit of a focal boost for prostate cancer on biochemical disease-free survival. (November 2020)